FY 2018 WISEWOMAN / Wise Choices Procedure Code Reference Chart
|
|
- Ashley Alexander
- 6 years ago
- Views:
Transcription
1 99203 Office or other outpatient visit for the evaluation and management of a new patient, a detailed history; a detailed examination; and medical decision making of low complexity. Usually the presenting problem(s) are of moderate. Physicians typically spend Office or other outpatient visit for the evaluation and management of a new patient, a comprehensive history; a comprehensive examination; and medical decision making of moderate complexity. Usually the presenting problem(s) are of moderate to high. Physicians typically spend Initial comprehensive preventive medicine evaluation and management of an individual /risk factor reduction interventions, and the ordering of appropriate immunizations(s), laboratory/diagnostic procedures, new patient; years Initial comprehensive preventive medicine evaluation and management of an individual /risk factor reduction interventions, and the ordering of appropriate immunizations(s), laboratory/diagnostic procedures, new patient; years Initial comprehensive preventive medicine evaluation and management of an individual /risk factor reduction interventions, and the ordering of appropriate immunizations(s), laboratory/diagnostic procedures, new patient; 65 years and over Straightforward problem of moderate Detailed history and P/E needed high glucose, or high blood pressure ( Alert or Emergency values) Complex problem of moderate to high Comprehensive history and P/E needed high glucose, and high blood pressure New patient between the ages of 18 and 39 New patient between the ages of 40 and 64 New patient age 65 and older FY18 1
2 99201 Office or other outpatient visit for the evaluation and management of a new patient, a problem focused history; a problem focused examination; and Usually, the presenting problems are self limited or minor. Physicians typically spend Office or other outpatient visit for the evaluation and management of a new patient, an expanded problem focused history; an expanded problem focused examination; and Usually, the presenting problem(s) are of low to moderate. Physicians typically spend Office or other outpatient visit for the evaluation and management of an established patient, which requires at least two of these three key components: an expanded problem focused history; an expanded problem focused examination; medical decision making of low complexity. Counseling and coordination of care with other providers or agencies are provided Usually, the presenting problem(s) are of low to moderate. Physicians typically spend Office or other outpatient visit for the evaluation and management of an established patient, which requires at least two of these three key components: Minor problem Problem focused history and P/E needed and treatment of borderline cholesterol. Straightforward problem of low/moderate Problem focused history and P/E needed high glucose, or high blood pressure (not Alert values) Straightforward problem of low/moderate Problem focused history and P/E needed high glucose, or high blood pressure Complex problem of moderate to high FY18 2
3 a detailed history; a detailed examination; medical decision making of moderate complexity. Usually the presenting problem(s) are of moderate to high. Physicians typically spend Periodic comprehensive preventive medicine reevaluation and management of an counseling/anticipatory /risk factor reduction interventions, and the ordering of appropriate immunization(s), laboratory/diagnostic procedures, established patient; years Periodic comprehensive preventive medicine reevaluation and management of an counseling/anticipatory /risk factor reduction interventions, and the ordering of appropriate immunization(s), laboratory/diagnostic procedures, established patient; years Periodic comprehensive preventive medicine reevaluation and management of an counseling/anticipatory /risk factor reduction interventions, and the ordering of appropriate immunization(s), laboratory/diagnostic procedures, established patient; 65 years and over Office or other outpatient visit for the evaluation and management of an established patient, that may not require the presence of a physician. Usually, the presenting problem(s) are minimal. Typically, 5 minutes are spent performing or supervising these services Office or other outpatient visit for the evaluation and management of an established patient, which requires at least two of these three components: a problem focused history; Comprehensive history and P/E needed high glucose, and high blood pressure Established patient between the ages of Established patient between the ages of Established patient age 65 and older and treatment of borderline cholesterol. Minor problem FY18 3
4 FY 2018 a problem focused examination; Usually, the presenting problem(s) are self limited or minor. Physicians typically spend Lipid panel. This panel must include the following: Cholesterol, serum, total Lipoprotein, direct measurement, high density cholesterol (HDL Cholesterol) Triglycerides QW Lipid panel. This panel must include the following: Cholesterol, serum, total Lipoprotein, direct measurement, high density cholesterol (HDL Cholesterol) Triglycerides (CLIA waived) high glucose, or high blood pressure (not Alert values) Lipid panel (TC, HDL, triglycerides) Lipid panel (TC, HDL, triglycerides) Test performed with Cholestech Collection of venous blood by venipuncture Venipuncture Glucose; quantitative, blood (except reagent strip) Plasma Glucose QW Glucose; quantitative, blood (except reagent strip) (CLIA waived) Plasma Glucose Test performed with Cholestech Hemoglobin; glycosylated (A1C) Hemoglobin A1C QW Hemoglobin; glycosylated (A1C) (CLIA waived) Hemoglobin A1C Performed with DCA or Cholestech GDX Unlisted preventive and medicine service Alert value case management Unlisted cardiovascular service or procedure Hypertension case management T1023 Screening to determine the appropriateness of an individual for participation in a New WISEWOMAN recruited specified program FY18 4
5 S5190 Wellness assessment, performed by a non physician Client is not ready to change: Make f/u call in 1 2 months S0315 Disease management program, initial assessment and initiation Client initiates medication adherence S0340 Lifestyle modification program for management of CVD 1st stage Client participated in 1 st health coaching session or Lifestyle Program encounter S0341 Lifestyle modification program for management of CVD 2 nd or 3 rd stage Client participates in two health coaching sessions after health coaching or LSP is complete S0342 Lifestyle modification program for management of CVD final stage Client completes health coaching or Lifestyle Program S0316 Disease management program, follow up/reassessment Outcome evaluation contact completed S T Patient education not otherwise listed non physician provider Preventive behavior change, intensive program of prevention of diabetes using a standardized diabetes prevention program curriculum, provided to individuals in a group setting, minimum 60 minutes, per day Client exhibits positive changes on outcome evaluation contact Client attends a Diabetes Prevention Program session FY18 5
Clinical Breast Examination N/A Yes Screening Mammogram $ TC $ 43.56
For the Period 07/01/2015 through 06/30/2016 Revised: 10/09/2015 Breast Procedures (1) Screening Clinical Breast Examination N/A Screening Mammogram 77057 $ 78.38 77057-TC $ 43.56 77057-26 $ 34.82 Follow-Up
More informationProcedure Description Modifier 33 Required? Screening test of visual acuity, quantitative, bilateral No Z Z00.129
Policy Name: Preventive Health Guidelines - Newborns and Children This policy applies only to non-grandfathered plans as defined in the Affordable Care Act section 1251. The following chart contains procedure,
More informationFY 2015 BCCCP Procedure Code Reference Chart
Procedure Reference Chart 77057 G0202 77055 G0206 77056 G0204 Screening mammography, bilateral (two view film study of each breast) Screening mammography producing direct digital image, bilateral, all
More informationFY 2017 MCRCEDP Procedure Code Reference Chart
45378-53 45380 45381 45382 45384 45385 48388 45390 ; Colonoscopy, flexible, proximal to splenic flexure; diagnostic, with or without collection of specimen(s) by brushing or washing, with or without colon
More informationMetabolic Monitoring Point of Care Testing
Metabolic Monitoring Point of Care Testing Committee on Provider Quality 5/16/18 Revised 8/2/18 Metabolic Monitoring Goals Identify treatable pathology in a high risk population and link to medical care
More information2017 Employee Wellness Health Assessment Report
Employee Wellness National Consortium for Building Healthy Academic Communities (BHAC) Healthier Tennessee Workplace 2017 Employee Wellness Health Assessment Report Blood Pressure 2017 (387 total) (National
More informationINDIANA HEALTH COVERAGE PROGRAMS
INDIANA HEALTH COVERAGE PROGRAMS PROVIDER CODE TABLES Medical Review Team s Due to possible changes in Indiana Health Coverage Programs (IHCP) policy or national coding updates, inclusion of a code on
More informationSelf-monitoring blood cholesterol (SMBC) testing: within-person day to day variation in a healthy volunteer
Address: Self-monitoring blood cholesterol (SMBC) testing: within-person day to day variation in a healthy volunteer Lipid Clinic, Department of Cardiology Basingstoke & North Hampshire Hospital Aldermaston
More informationAchieving Bright Futures
Implementation of the ACA Pediatric Preventive Services Provision To ensure that all services children need are provided, it is critical that insurers pay for each separately reported service at a level
More informationNutrition Care Process. Catherine Villafranca & Anthony Richitt
Nutrition Care Process Catherine Villafranca & Anthony Richitt Nutrition Care Process -According to eatrightpro.org, the Nutrition Care Process is a systematic approach to providing high-quality nutrition
More informationNOTE: Please append modifier 33 when indicated. If modifier 33 is not appended, regular plan benefits will be applied.
Policy name: Health Guidelines - Men This policy applies only to non-grandfathered plans as defined in the Affordable Care Act section 1251. The following chart contains procedure, diagnosis and modifier
More information2013 Hypertension Measure Group Patient Visit Form
Please complete the form below for 20 or more unique patients meeting patient sample criteria for the measure group for the current reporting year. A majority (11 or more) patients must be Medicare Part
More informationCustomer Bulletin January 2017
Customer Bulletin January 2017 Revised s: PTS Panels Multi-Chemistry Controls (Lot Numbers MC23, MC24, MC25, and MC26) (REF 721) Summary: New range cards has been issued for PTS Panels Multi-Chemistry
More information8/12/2016. Outline. New CPT Code for Pre-Diabetes Education. Medicare Proposed Coverage for DPP. Medicare Proposed Coverage for DPP cont.
New CPT Code for Pre-Diabetes Education 0403T: Preventive behavior change, intensive program of prevention of diabetes using a standardized diabetes prevention program curriculum, provided to individuals
More informationPrevention of Fetal Alcohol Spectrum Disorder Coding Basics
Prevention of Fetal Alcohol Spectrum Disorder Coding Basics The Centers for Disease Control and Prevention (CDC) urges pregnant women not to drink alcohol during pregnancy. Per the CDC, there is no known
More informationClinical and Economic Summary Report. for Employers
Clinical and Economic Summary Report for Employers Magaly Rodriguez de Bittner, PharmD, CDE, FAPhA Director, P 3 Program Dawn Shojai, PharmD Assistant Director, P 3 Program P 3 Clinical & Economic Summary
More informationTo reduce the risk of cardiovascular disease and diabetes among Oklahoma state employees.
E Nancy A. Haller, MPH, CHES, Manager, State Wellness Program M PLOYEES To reduce the risk of cardiovascular disease and diabetes among Oklahoma state employees. To suspend or decrease the rising costs
More informationTable of Contents. Early Identification Chart Biometric Screening Comprehensive Cardiovascular Disease Risk Assessment...
Public Safety Table of Contents Early Identification Chart... 1 Biometric Screening... 2 Comprehensive Cardiovascular Disease Risk Assessment.... 2 Recommended after Comprehensive Cardiovascular Disease
More information(a) y = 1.0x + 0.0; r = ; N = 60 (b) y = 1.0x + 0.0; r = ; N = Lot 1, Li-heparin whole blood, HbA1c (%)
cobas b system - performance evaluation Study report from a multicenter evaluation of the new cobas b system for the measurement of HbAc and lipid panel Introduction The new cobas b system provides a point-of-care
More informationProgram Summary. The CT Early Detection and Prevention Program
Program Summary The CT Early Detection and Prevention Program 1 The CT Early Detection and Prevention Program is part of the Center for Disease Control and Prevention s (CDC) National Breast and Cervical
More informationKIDNEY DISEASE is associated with a number
PATIENT EDUCATION Column Editor: Beth McQuiston, MS, RD, LD Tips for Cholesterol Control in Patients on Hemodialysis Philippa Norton Feiertag, MEd, RD, CSR, LD Submitted by Philippa Norton Feiertag, MEd,
More informationSouth Bay Worksite Wellness. Health Coaching Report San Mateo County 2013 Health Coaching Program
South Bay Worksite Wellness Health Coaching Report Health Coaching Program Introduction Project Details Services were delivered to employees who are Kaiser Permanente members. Telephonic outreach was completed
More informationMEDICAL POLICY MEDICAL POLICY DETAILS POLICY STATEMENT. Page: 1 of 6
Page: 1 of 6 MEDICAL POLICY MEDICAL POLICY DETAILS Medical Policy Title MEDICAL/ NON-SURGICAL WEIGHT MANAGEMENT PROGRAMS and SERVICES Policy Number 11.01.01 Category Contract Clarification Effective Date
More informationSession 21: Heart Health
Session 21: Heart Health Heart disease and stroke are the leading causes of death in the world for both men and women. People with pre-diabetes, diabetes, and/or the metabolic syndrome are at higher risk
More informationNOTE: Please append modifier 33 when indicated. If modifier 33 is not appended, regular plan benefits will be applied.
Policy name: Preventive Health Guidelines - Men The following chart contains procedure and diagnosis code combinations that identify services covered under HMSA's Preventive Health s policy. * For professional
More informationAina Blood Monitoring System
Aina Blood Monitoring System Analytical Performance Summary The Aina Blood Monitoring System is a high quality and versatile multi-parameter diagnostic platform that is CE-marked and approved for sale
More informationNormal cholesterol level for men over 50
Normal cholesterol level for men over 50 Understand what your cholesterol levels mean: Total, LDL, for men and 50 mg per dl their respective numbers have to stay over or under a particular level,. 24-4-2017
More informationCardiac rehabilitation/secondary prevention programs
AHA/AACVPR Scientific Statement Core Components of Cardiac Rehabilitation/Secondary Prevention Programs A Statement for Healthcare Professionals From the American Heart Association and the American Association
More informationAccuracy and Precision in Point-of-Care Lipid Testing: CardioChek P A Point-of-Care Test System and PTS Panels Test Strips
Accuracy and Precision in Point-of-Care Lipid Testing: CardioChek P A Point-of-Care Test System and PTS Panels Test Strips Sponsored by Arthur Roberts, MD of The Living Heart Foundation The Living Heart
More informationAttention STAR Providers: Physical, Occupational, and Speech Therapy Benefits for All Ages to Change for Texas Medicaid September 1, 2017
Attention STAR Providers: Physical, Occupational, and Speech Therapy Benefits for All Ages to Change for Texas Medicaid September 1, 2017 Effective for dates of service on or after September 1, 2017, physical
More informationPreventive Cardiology
Preventive Cardiology 21 Volume The Preventive Cardiology and Rehabilitation Prevention Outpatient Visits 7,876 Program helps patients identify traditional and Phase I Rehab 9,932 emerging nontraditional
More informationPlasma fibrinogen level, BMI and lipid profile in type 2 diabetes mellitus with hypertension
World Journal of Pharmaceutical Sciences ISSN (Print): 2321-3310; ISSN (Online): 2321-3086 Published by Atom and Cell Publishers All Rights Reserved Available online at: http://www.wjpsonline.org/ Original
More informationB. Patient has not reached the percentage reduction goal with statin therapy
Managing Cardiovascular Risk: The Importance of Lowering LDL Cholesterol and Reaching Treatment Goals for LDL Cholesterol The Role of the Pharmacist Learning Objectives 1. Review the role of lipid levels
More informationMaryland-National Capital Park Police Prince George s County Division DIVISION DIRECTIVE DISTRIBUTION
Maryland-National Capital Park Police Prince George s County Division DIVISION DIRECTIVE TITLE PROCEDURE NUMBER SECTION DISTRIBUTION EFFECTIVE DATE REVIEW DATE Administrative Procedures A 12/01/04 REPLACES
More informationAdvanced Topics in DBT: The Art of Moving from Conceptualization to Exposure for Emotional Avoidance
Conceptualization to Exposure for Emotional Avoidance This 4-day course will include one day of advanced training on DBT case conceptualization and three days of training on exposure in DBT Stage 1 and
More informationPolymer Technology Systems, Inc. CardioChek PA Comparison Study
Polymer Technology Systems, Inc. CardioChek PA Comparison Study Evaluation Protocol: Accuracy Precision Clinical Correlation PTS Panels Lipid Panel Test Strips For Use in Comparisons to a Reference Laboratory
More informationDirector, Employee Health & Productivity. Coordinator, Employee Health & Productivity
Director, Employee Health & Productivity Coordinator, Employee Health & Productivity Table 2:. ChartE: Female HDL Cholesterol Risk Levels Optimal Borderline High Risk 80% 60% 40% 20% 0% LDL Cholesterol
More information1 PROTOCOL. Comparison Study Summary. Springs Memorial Hospital. Springs Memorial Hospital 800 W. Meeting St. Lancaster, SC (803)
Comparison Study Summary Springs Memorial Hospital 800 W. Meeting St. Lancaster, SC 29720 (803) 286-1480 February 10, 2016 1 PROTOCOL This evaluation was conducted on February 10, 2016 at Springs Memorial
More informationModule 2. Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension
Module 2 Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension 1 Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored,
More informationHeart Disease and Diabetes Teaching Module
Heart Disease and Diabetes eaching Module Pre-est 1 Cardiovascular complications will affect of people with diabetes. a. 75% b. 15% c. 99% 2 rue or alse? Chronic high blood sugars can cause arteries to
More informationISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP OVERVIEW
ISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP OVERVIEW 2014 PQRS OPTIONS F MEASURES GROUPS: 2014 PQRS MEASURES IN ISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP: #204. Ischemic Vascular Disease (IVD):
More informationUpdate on Lipid Management in Cardiovascular Disease: How to Understand and Implement the New ACC/AHA Guidelines
Update on Lipid Management in Cardiovascular Disease: How to Understand and Implement the New ACC/AHA Guidelines Paul Mahoney, MD Sentara Cardiology Specialists Lipid Management in Cardiovascular Disease
More informationLipoprotein Particle Profile
Lipoprotein Particle Profile 50% of people at risk for HEART DISEASE are not identified by routine testing. Why is LPP Testing The Most Comprehensive Risk Assessment? u Provides much more accurate cardiovascular
More information2/27/2017. Point of Care Testing- current and future opportunities for pharmacists in Virginia. Financial Disclosures. Pre-Assessment.
Point of Care Testing- current and future opportunities for pharmacists in Virginia Objectives Define the Pharmacy Practice Act in Virginia M AR G AR E T L AN D I S, P H AR M. D. K R O G E R P H AR M AC
More informationEvidence-Based Medicine
Assessing Risks for Cardiovascular Disease in a Pharmacy Setting Jeff Rochon, Pharm.D. Director of Pharmacy Care Services Washington State Pharmacy Association Evidence-Based Medicine Use established guidelines
More informationDiabetic Dyslipidemia
Diabetic Dyslipidemia Dr R V S N Sarma, M.D., (Internal Medicine), M.Sc., (Canada), Consultant Physician Cardiovascular disease (CVD) is a significant cause of illness, disability, and death among individuals
More informationSCIENTIFIC STUDY REPORT
PAGE 1 18-NOV-2016 SCIENTIFIC STUDY REPORT Study Title: Real-Life Effectiveness and Care Patterns of Diabetes Management The RECAP-DM Study 1 EXECUTIVE SUMMARY Introduction: Despite the well-established
More informationSection 02: Health Appraisal / Risk Stratification
Section 02: Health Appraisal / Risk Stratification ACSM Guidelines: Chapter 2 Pre Participation Health Screening and Risk Stratification ACSM Manual: Chapter 2 Pre Assessment Screening HPHE 4450 Dr. Cheatham
More informationBest practices for a successful wellness screening program
Health & Wellness Best practices for a successful wellness screening program Identify risk. Increase engagement. Incite change. Identifying health risks in your employee population People at risk for chronic
More informationDo OurHealth primary care clinics improve health & reduce healthcare costs? OurHealth Patient Engagement Analysis June 2018
Question: Do OurHealth primary care clinics improve health & reduce healthcare costs? OurHealth Patient Engagement Analysis June 2018 An examination of health improvements, utilization & cost of care for
More informationCANadian Pediatric Weight management Registry CANPWR. UPDATE ON PROGRESS CANNeCTIN Meeting 27.April.2010
CANadian Pediatric Weight management Registry CANPWR UPDATE ON PROGRESS CANNeCTIN Meeting 27.April.2010 KM Morrison Hamilton (PI) Geoff Ball Edmonton, AB JP Chanoine Vancouver, BC Mark Tremblay Ottawa,
More informationZarmine Naccashian, PhD, GNP, RN,CDE Assistant Professor, CSUN Felicitas A. dela Cruz, RN, DNSc, FAANP Professor and Director, APU Center for the
Zarmine Naccashian, PhD, GNP, RN,CDE Assistant Professor, CSUN Felicitas A. dela Cruz, RN, DNSc, FAANP Professor and Director, APU Center for the Study of Health Disparities To describe the risk factors
More information... CME/CPE QUIZ... CME/CPE QUESTIONS
CME/CPE QUESTIONS Continuing Medical Education Accreditation The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 2 credit hours in category 1 credit toward
More information4. resisted training ** OR resistance training * OR resisted exercise ** OR resistance exercise ** OR strength training ** OR strength exercise **
Supplementary Table 1. Search strategy (up to January 10 th 2015). MEDLINE Result: 253 studies 1. clinical trial ** OR controlled trial ** OR randomized controlled trial * OR randomised controlled trial
More informationEvaluating the Impact of a Pharmacist-Care Program for Persons with Diabetes
Evaluating the Impact of a Pharmacist-Care Program for Persons with Diabetes Prepared for: National Community Pharmacists Association Foundation by: David Nau, R.Ph., Ph.D. Assistant Professor Josh Blevins
More informationNOTE: Please append modifier 33 when indicated. If modifier 33 is not appended, regular plan benefits will be applied.
Policy name: Preventive Health Guidelines - Men The following chart contains procedure and diagnosis code combinations that identify services covered under HMSA's Preventive Health s policy. * For professional
More information2013 UPDATE ON PREVENTION & SCREENING IN THE ELDERLY West Virginia Geriatrics Society October 3, 2013
2013 UPDATE ON PREVENTION & SCREENING IN THE ELDERLY West Virginia Geriatrics Society October 3, 2013 Joy Pelfrey, RN, MSN, FNP, NEA-BC Director of Senior Service Line Objective Providers will understand
More informationCase Study: Chris Arden. Peripheral Arterial Disease
Case Study: Chris Arden Peripheral Arterial Disease Patient Presentation Diane is a 65-year-old retired school teacher She complains of left calf pain when walking 50 metres; the pain goes away after she
More informationKnow Your Number Aggregate Report Single Analysis Compared to National Averages
Know Your Number Aggregate Report Single Analysis Compared to National s Client: Study Population: 2242 Population: 3,000 Date Range: 04/20/07-08/08/07 Version of Report: V6.2 Page 2 Study Population Demographics
More informationEvidence-Based Medicine
Assessing Risks for Cardiovascular Disease in a Pharmacy Setting Jeff Rochon, Pharm.D. Director of Pharmacy Care Services Washington State Pharmacy Association Evidence-Based Medicine Use established guidelines
More informationATP III (Adult Treatment Panel III) CLASSIFICATION C IN ADULTS
LABORATORY AND RISK FACTORS OF ATHEROSCLEROSIS S R. Mohammadi Biochemist (Ph.D.) Faculty member of Medical Faculty RISK FACTORS FOR CHD Clinical Risk Factors Laboratory Risk Factors MAJOR CLINICAL RISK
More informationKey Elements in Managing Diabetes
Key Elements in Managing Diabetes Presentor Disclosure No conflicts of interest to disclose Presented by Susan Cotey, RN, CDE Lennon Diabetes Center Stephanie Tubbs Jones Health Center Cleveland Clinic
More informationPrimary Prevention Patients aged 85yrs and over
Rotherham Guideline for the management of Non-Familial Hypercholesterolaemia Type 1 Diabetes Offer lifestyle advice Over 40yrs of age? Diabetic for more than 10 years? Established nephropathy? Other CVD
More informationClient Report Screening Program Results For: Missouri Western State University October 28, 2013
Client Report For: Missouri Western State University October 28, 2013 Executive Summary PROGRAM OVERVIEW From 1/1/2013-9/30/2013, Missouri Western State University participants participated in a screening
More informationMeasure Owner Designation. AMA-PCPI is the measure owner. NCQA is the measure owner. QIP/CMS is the measure owner. AMA-NCQA is the measure owner
2011 EHR Measure Specifications The specifications listed in this document have been updated to reflect clinical practice guidelines and applicable health informatics standards that are the most current
More informationHospital Authority Convention 2010 Presented by : Dr Cheng Ming Kin Medical Officer,Department of Medicine Tseung Kwan O Hospital
Hospital Authority Convention 2010 Prevalence of Cardiovascular Risk Factors, the Metabolic Syndrome and the 10-year risk for Coronary Heart Disease in the Staff of Tseung Kwan O Hospital Presented by
More informationDaniel M. Rosney, Sr.
Work Address: Department of Kinesiology P244 Pearson Hall 215.204.2974 daniel.rosney@temple.edu Revised 08/17 EDUCATION Ph.D. in Exercise and Nutrition Sciences 2017 B.S./M.S. in Exercise Science/Nutrition
More informationFigure S1. Comparison of fasting plasma lipoprotein levels between males (n=108) and females (n=130). Box plots represent the quartiles distribution
Figure S1. Comparison of fasting plasma lipoprotein levels between males (n=108) and females (n=130). Box plots represent the quartiles distribution of A: total cholesterol (TC); B: low-density lipoprotein
More informationWhy are NICE guidelines and standards important and relevant to us?
Why are NICE guidelines and standards important and relevant to us? Dr Liz England GP, Laurie Pike health centre RCGP Mental Health Clinical and Commissioning Lead SWB CCG Mental Health Lead NIHR Clinical
More informationAndrew Cohen, MD and Neil S. Skolnik, MD INTRODUCTION
2 Hyperlipidemia Andrew Cohen, MD and Neil S. Skolnik, MD CONTENTS INTRODUCTION RISK CATEGORIES AND TARGET LDL-CHOLESTEROL TREATMENT OF LDL-CHOLESTEROL SPECIAL CONSIDERATIONS OLDER AND YOUNGER ADULTS ADDITIONAL
More informationCOMMUNITY EFFORTS TO PREVENT TYPE 2 DIABETES
COMMUNITY EFFORTS TO PREVENT TYPE 2 DIABETES 15 th Population Health Colloquium March 23, 2015 Marti Macchi, MEd., MPH Senior Consultant National Association of Chronic Disease Directors Today s Agenda
More informationTHE EFFECT OF VITAMIN-C THERAPY ON HYPERGLYCEMIA, HYPERLIPIDEMIA AND NON HIGH DENSITY LIPOPROTEIN LEVEL IN TYPE 2 DIABETES
Int. J. LifeSc. Bt & Pharm. Res. 2013 Varikasuvu Seshadri Reddy et al., 2013 Review Article ISSN 2250-3137 www.ijlbpr.com Vol. 2, No. 1, January 2013 2013 IJLBPR. All Rights Reserved THE EFFECT OF VITAMIN-C
More informationWhy do we need SD LipidoCare?
SD Biosensor, Inc. Innovative Global Leader of In Vitro Diagnostics Total supplier of Blood Glucose Monitoring System and Lipid Analyzer System in vitro diagnostics test kits for Point of Care Testing
More informationKeywords: Type 2 DM, lipid profile, metformin, glimepiride ABSTRACT
Human Journals Research Article September 2015 Vol.:4, Issue:2 All rights are reserved by K. Saravanan et al. Effects of Monotherapy and Combination Therapy Involving Metformin and Glimepiride on HbA1c
More informationImproving Target LDL-C Levels in Diabetic Patients Using the Electronic Health Record: Primary Care Practice Improvement Project
University of Portland Pilot Scholars Nursing Graduate Publications and Presentations School of Nursing 2015 Improving Target LDL-C Levels in Diabetic Patients Using the Electronic Health Record: Primary
More informationOhio. SAMPLE NCCI Edits*** Navigate to the Overall Coding Sheet
SAMPLE NCCI *** Encounter +90785 Use 90785 in conjunction with codes for diagnostic psychiatric evaluation [90791, 90792], psychotherapy [90832, 90834, 90837], psychotherapy when performed with an evaluation
More informationPrevention and Management Of Obesity Adolescents & Children
Prevention and Management Of Obesity Adolescents & Children The Pediatric Obesity Prevention and Treatment Toolkit is available at: https://www.optimahealth.com/providers/clinical-reference/pediatric-obesity-prevention-andtreatment-toolkit
More informationGender: M Chart No: Fasting: Yes. Boston Heart HDL Map TM Test 1 ApoA-I (mg/dl) levels in HDL particles. α Range > <14 mg/dl. α-2 50.
Pro vider: Ordering Provider 123 Main Street Anytown, ST 12345 Account No: DOB: 00/00/1950 Framingham Risk Score: Patient Info: FAMILY HIST CVD Lipid, Lipoprotein and Apolipoprotein Tests Total Cholesterol
More informationAlere Cholestech LDX Laboratory Procedure Lipid Profile GLU TC HDL GLU TC GLU Lipid Profile TC HDL TC
Laboratory Name: Laboratory Address: Date of this packet: Insert Revision: 26196en Rev. A 2010/12 Alere Cholestech LDX Laboratory Procedure Lipid Profile GLU TC HDL GLU TC GLU Lipid Profile TC HDL TC This
More informationThe National Diabetes Prevention Program in Washington State March 2012
The National Diabetes Prevention Program in Washington State March 2012 Session Objectives 1. Overview of pre-diabetes. 2. Describe the Diabetes Prevention Program (DPP). 3. Eligibility for the DPP. 4.
More informationSection 1: 1: Trends. Section 2: 2: Comparisons to to Overall Portland Area Area Results for for
Section 1: 1: Trends 1 Patients in the Diabetes Register 2 Gender of Patients with Diabetes 2 Age of Patients with Diabetes 3 Diabetes Type 3 Duration of Diabetes 4 Weight Control 5 Hemoglobin A1c 6 Blood
More informationWISEWOMAN/Wise Choices Policy Manual
WISEWOMAN/Wise Choices Policy Manual Fiscal Year 2017/2018 October 1, 2017 to September 30, 2018 WISEWOMAN/Wise Choices Program Policies Table of Contents MDHHS Contact Information 3 WISEWOMAN Program
More informationThe New Gold Standard for Lipoprotein Analysis. Advanced Testing for Cardiovascular Risk
The New Gold Standard for Lipoprotein Analysis Advanced Testing for Cardiovascular Risk Evolution of Lipoprotein Testing The Lipid Panel Total Cholesterol = VLDL + LDL + HDL Evolution of Lipoprotein Testing
More informationDiabetes, Diet and SMI: How can we make a difference?
Diabetes, Diet and SMI: How can we make a difference? Dr. Adrian Heald Consultant in Endocrinology and Diabetes Leighton Hospital, Crewe and Macclesfield Research Fellow, Manchester University Relative
More informationCoach on Call. Please give me a call if you have more questions about this or other topics.
Coach on Call It was great to talk with you. Thank you for your interest in. I hope you find this tip sheet helpful. Please give me a call if you have more questions about this or other topics. As your
More informationScreening Results. Juniata College. Juniata College. Screening Results. October 11, October 12, 2016
Juniata College Screening Results Juniata College Screening Results October 11, 2016 & October 12, 2016 JUNIATA COLLEGE The J.C. Blair Hospital CARES team screened 55 Juniata College employees on October
More informationDiabetes Mellitus. Eiman Ali Basheir. Mob: /1/2019
Diabetes Mellitus Eiman Ali Basheir Mob: 091520385 27/1/2019 Learning Outcomes Discuss the WHO criteria for Diabetes Mellitus diagnosis Describe the steps taken to confirm diagnosis Interpret GTT. Discuss
More informationCLINICAL GUIDELINE. Document No:CG38 *All Sites Management of adult patients referred to South Tees University Hospitals for hypertension.
GUIDELINE CLINICAL GUIDELINE Document No:CG38 *All Sites Management of adult patients referred to South Tees University Hospitals for hypertension. TITLE Management of adult patients referred to South
More informationAll-in-One Portable Lipid Analyzer
All-in-One Portable Lipid Analyzer Small in Size! Big in Performance! Clinically proven accuracy & precision Evaluation study Extensive clinical studies proved the accuracy of the SD LipidoCare system
More informationDiabetes Management: Interventions Engaging Community Health Workers
Diabetes Management: Interventions Engaging Community Health Workers Community Preventive Services Task Force Finding and Rationale Statement Ratified April 2017 Table of Contents Intervention Definition...
More information15/9/2017 4:23:00PM 15/9/2017 4:26:23PM 20/9/2017 5:00:25PM A/c Status. Test Name Results Units Bio. Ref. Interval < >40.00 mg/dl <150.
Lab No 135091257 Age 30 Years Gender Male 15/9/2017 42300M 15/9/2017 42623M 20/9/2017 50025M Ref By UNKNWON Final Test Results Units Bio Ref Interval SWASTH LUS DIABETES ANEL LIID ROFILE, BASIC, SERUM
More informationMipomersen (ISIS ) Page 2 of 1979 Clinical Study Report ISIS CS3
(ISIS 301012) Page 2 of 1979 2 SYNOPSIS ISIS 301012-CS3 synopsis Page 1 Title of Study: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics,
More informationTotal Wellness BIOMETRIC SCREENING. What is Biometric Screening? MVNA Biometric Screening includes:
Total Wellness BIOMETRIC SCREENING What is Biometric Screening? MVNA Biometric Screening includes: BODY MASS INDEX BLOOD PRESSURE BLOOD SUGAR LIPID PROFILE 1 Why do we screen? These numbers are among the
More informationEffects of a Community Pharmacist-Based Diabetes Patient-Management Program on Intermediate Clinical Outcome Measures
RESEARCH Effects of a Community Pharmacist-Based Diabetes Patient-Management Program on Intermediate Clinical Outcome Measures OBJECTIVES: Evaluate a community pharmacist-based diabetes patient-management
More informationDiabetes Audit Results, Portland Area, Site-Specific Trends
Site-Specific Trends The following report contains information from your program's annual diabetes audit submission to the Indian Health Service over the past few years. The report was prepared for your
More informationEvidence-Based Medicine
Assessing Risks for Cardiovascular Disease: Blood Pressure Measurement and Lipid Profile Screenings Jeff Rochon, Pharm.D. Director of Pharmacy Care Services Washington State Pharmacy Association Evidence-Based
More informationORIGINAL REPORTS: CHRONIC DISEASE MANAGEMENT AND PREVENTION
ORIGINAL REPORTS: CHRONIC DISEASE MANAGEMENT AND PREVENTION QUALITY IMPROVEMENT FOR PREVENTION OF CARDIOVASCULAR DISEASE AND STROKE IN AN ACADEMIC FAMILY MEDICINE CENTER: DO RACIAL DIFFERENCES IN OUTCOME
More informationWhat is Diabetes Mellitus?
Normal Glucose Metabolism What is Diabetes Mellitus? When the amount of glucose in the blood increases, After a meal, it triggers the release of the hormone insulin from the pancreas. Insulin stimulates
More informationTask Force Finding and Rationale Statement
Cardiovascular Disease Prevention and Control: Reducing Out-of- Pocket Costs for Cardiovascular Disease Preventive Services for Patients with High Blood Pressure and High Cholesterol Task Force Finding
More informationComprehensive Treatment for Dyslipidemias. Eric L. Pacini, MD Oregon Cardiology 2012 Cardiovascular Symposium
Comprehensive Treatment for Dyslipidemias Eric L. Pacini, MD Oregon Cardiology 2012 Cardiovascular Symposium Primary Prevention 41 y/o healthy male No Medications Normal BP, Glucose and BMI Social History:
More information